News

Kiran Mazumdar-Shaw conferred with Honorary Doctorate from Deakin University, Australia

Kiran has been recognized for her pioneering entrepreneurial role in the field of biotechnology and for her sustained significant contribution to Industry-Academia collaboration between Australia & India.

Read More

Mar 14, 2019

By : Team ABLE

DBT shares electronic library resources with scientists of DBT funded ongoing projects

DBT has announced that DeLCON resources are now available to all the scientists (PIs, Co-PIs etc.) of DBT funded ongoing projects under ‘Fair Use Policy’ through indirect access.

Read More

Mar 14, 2019

By : Team ABLE

DBT and TERI set up platform to orient nanobiotechnology research towards real-world solutions

The platform will focus on promoting translational research to convert nanobiotechnology research to practical applications

Read More

Mar 14, 2019

By : Team ABLE

FDA approves new generic valsartan; Alkem Laboratories bags the grant

U.S. Food and Drug Administration has approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure.

Read More

Mar 13, 2019

By : Team ABLE

Piramal to launch Cinacalcet with partner Slate Run Pharmaceuticals’ aid in the US

Cinacalcet tablets are indicated for the treatment of secondary hyperthyroidism in adult chronic kidney disease patients on dialysis and hypercalcemia in adult patients with parathyroid carcinoma.

Read More

Mar 13, 2019

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights